共 50 条
- [37] Cost-Effectiveness of Tocilizumab Monotherapy Vs. Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1037 - S1038
- [40] Factors Predicting 2 Years of Remission and Low Disease Activity in Rheumatoid Arthritis Patients Treated with TNF-inhibitors [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2017, 19 (08): : 467 - 472